RE: Medium-Term High Yield15 Nov 2021 16:39
Hi Auson - further to the link you provided (Sat 14.43). I had an issue with Morningstar MS back in 2018. I was confused by MS reporting that Double A and Amjad Bseisu held the same amount of shares. They actually held 103,258,316 mio whilst Morningstar had 2 similar amounts totalling 207Mio. This was over a period of several years so I naturally stopped trusting Morningstar. Back in 2017 they had AA and AB holding 71,405,331 EACH. I assumed it was sloppy records and my email to EnQuest IR confirmed. It also told me that there is little importance placed on these figures as the company trusts its own figures far more and any company worth its salt would do the same. Information that costs you nothing often has the same value. There seemed to be little regulatory control in this area and years later ARCM confirmed this.
Today we have Baillie Gifford with a much lower percentage but I have never seen a reduction RNS. Maybe I missed it? They hold 2.68% with MS and 4.99 with FT (that’s a 42mio share difference). Cobas has 3.03% with FT (which I believe is correct) whilst MS have 2.29% in 2 amounts. That is why I don’t trust the figures and anybody who does is being ingenuous when so easily proved otherwise and I’m no Sherlock Holmes (I leave that to Therapist who is, although he plays it down).
It might actually help understand some of the share shuffling recently. Maybe Baillie Gifford unloaded some to the hedge funds. Perhaps (and I’m guessing) that is the record of the deal – Helikon and Cobas issuing RNS’s. Only one side has to own up?
There are thousands of moving parts that make up a stock quote and this is only one of them. If you want another layer of confusion the major shareholders on the EnQuest.com site under Investors has BG with c. 96mio but that is almost a year old. The company probably does care but it doesn't appear to be obligatory or policed too well. They worry more about shorters but I'm just as interested in the longers.